🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This single-blinded, randomized controlled trial (RCT) will evaluate the ad...
Status
Recruiting
Location
Faculty of Physical Therapy, Al Hayah University
Start Date
2025-04-15
Trial ID
NCT06913920
The primary purpose for this study is to support the hypothesis (pilot data...
Status
Recruiting
Location
Desert Oasis Healthcare
Start Date
2023-09-22
Trial ID
NCT05650541
Treatments Being Tested
The purpose of this research study is to look at overall health status and ...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2014-02-28
Trial ID
NCT02057770
This phase II trial studies the side effects and how well lower doses of bo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02082405
This randomized phase III trial is comparing two different combination chem...
Status
Completed
Location
Children's Oncology Group
Start Date
2002-09
Trial ID
NCT00003958
RATIONALE: Biological therapies, such as therapeutic autologous lymphocytes...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2006-12
Trial ID
NCT00438984
This randomized phase II trial studies how well giving bortezomib with or w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2012-12-07
Trial ID
NCT01706666
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2006-09-26
Trial ID
NCT00274924
This phase I/2 trial studies the side effects and best dose of activated na...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2014-08-11
Trial ID
NCT01898793
This phase I/II trial studies the side effects and best dose of lenalidomid...
Status
Terminated
Location
University of Nebraska Medical Center
Start Date
2010-03-04
Trial ID
NCT01093183